Company Profile
The Dormir, Inc. Board of Directors is comprised of the leading Bioscience and Healthcare business minds in the U.S. today. It is their deep knowledge and expertise in these industries that drives the success of Domir and its subsidiaries.
Hover on a headshot below to view a bio.
Timothy J. Miller
Chairman of the Board
An Indianapolis native and 30 year expert of provider side healthcare services through partnering with physicians. The President and Co-Founder of the world’s first Mobile Cardiac Catheter Laboratory—Mobile Diagnostics, Incorporated. Chief Executive Officer of a mobile and modular imaging system manufacturer—MSR Technologies. And the President of a business consultancy for Physicians that created unique ownership models for Imaging Centers, Surgery Centers, and Specialty Hospitals—Medical Development Associates
Jeff Collison
President, CHL Medical Partners
Jeff has been investing in seed and early stage biotechnology and healthcare services companies for over 25 years. He has been actively involved in the founding of a number of life sciences companies including Genetic Systems, Inc., Celgene Corporation (Nasdaq: CELG), Incyte Corporation (formerly Incyte Pharmaceuticals, Inc., Nasdaq: INCY), and Neurogen Corporation (Nasdaq: NRGN), as well as numerous healthcare services companies including Intensiva healthcare Corporation and SemperCare, Inc.
Jeff is a graduate of Yale University and Harvard Business School.
Michael F. Elliot
General Partner, Noro-Moseley Partners
Mike Elliott joined NMP in 2005 with 21 years of successful venture capital investment experience. Mike invested primarily in technology and business services companies, at early and growth stages of development, and has continued that focus at NMP.
Mike currently serves on the Board of the National Venture Capital Association and has served on the Executive Committee of the NASBIC Board of Governors. He is extensively involved in North Carolina’s entrepreneurial community and serves as Board Chair of the Council for Entrepreneurial Development in Research Triangle Park. Mike received a BS in Mathematics and an MBA from the University of North Carolina, where he was both a Morehead Scholar and Maurice Lee Fellow.
Juan Enriquez
Managing Director, Excel Medical Ventures
Mr. Enriquez was the founding Director of the Harvard Business School’s Life Sciences Project. His best-selling book, As The Future Catches You, provided an early and accurate blue print of how a bio-based economy changes industries and corporations. He became an active angel investor, and then founded Biotechonomy Ventures, a successful fund that invested in highly promising life science companies such as BioTrove, a CB Health Ventures portfolio company, and Xcellerex. Throughout his career, Mr. Enriquez has successfully guided many companies – as CEO, director, investor, or president.
Most recently, he co-founded and led the financing for Drs. J. Craig Venter and Hamilton Smith’s new company, Synthetic Genomics, Inc. He is also a world authority on the economic impact of life sciences on business, working directly with the CEOs of a number of Fortune Fifty companies, as well as various heads of state, on how to adapt to a world where the dominant language is shifting from the digital towards the language of life. He graduated from Harvard with a B.A. and an M.B.A., both with honors.
R. Jeffrey Taylor
President and Chief Operating Officer, IPC: The Hospitalist Company
Mr. Taylor has been President and Chief Operating Officer since he joined IPC in July 2000, and currently serves as a member of their quality committee. Mr. Taylor received a B.S. from the University of Utah and a J.D. from the University of Utah College of Law.
Mr. Taylor has more than 25 years of experience in the areas of acute-care, sub-acute care and the outpatient dialysis segments of the healthcare industry. Mr. Taylor’s qualifications to serve on our Board of Directors include his many years experience as a senior executive responsible for operations in multi-state public and private healthcare services companies, his legal background in healthcare and his service on the board of directors of another healthcare services company.
Caleb Winder
Vice President, Excel Medical Ventures
Mr. Winder brings strong experience in healthcare, sales and marketing, finance and venture to Dormir, Inc. In 2005, Mr. Winder assisted in the founding of Synthetic Genomics, Inc. including securing the initial and second financings of the company, and serving as the initial Director of Finance. Mr. Winder served as member of the board of Xcellerex, Inc which he and Mr. Enriquez restructured and drove to successful financings.
Mr. Winder spent his early career as an award-winning sales and marketing professional for companies that specialize in medical equipment, diagnostics systems, and software, including Midmark Corporation, Medical Graphics Corporation (acquired by Angeion), and Moldflow Corporation (acquired by Autodesk). Mr. Winder also worked in Business Development for GeneXP Biosciences (now Xceed Molecular) and is a member of the Entrepreneurial Council of the Wake Forest Translational Science Institute.
He received his M.B.A. from Babson College, magna cum laude, where he honored as a Babson Fellow in the Center for Technology Enterprise and was elected as Director of the Entrepreneurial Finance Group. He received a B.A. in Biology with a minor in Economics from Colby College.






